- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06229730
Normative Data of Vestibular and Postural Function in Danish Children (VASIC)
Vestibular ASsessment In Children - Balance Function in Normal Children and Specific Risk Groups (VASIC)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Balance problems in children are an overlooked issue in the Danish healthcare system. Dysfunction of the vestibular system, i.e. vestibular dysfunction (VD), can have significant consequences for children's development and quality of life.
Knowledge about the prevalence of vestibular impairment and normative data of vestibular function in the Danish pediatric population is missing.
The investigators aim for a child friendly and reliable vestibular test protocol in the study. According to the investigators studies as well as international reports, the investigators have chosen a vestibular test protocol with Video Head Impulse Test (v-HIT), cervical and ocular Vestibular Evoked Myogenic Potential (c and oVEMP) as the tests are feasible, valid, and child friendly. To evaluate overall balance ability, the children are tested on a Computerized Dynamic Posturography.
The aim of the study is to provide normative data of vestibular function in the general Danish pediatric population. Thus, the investigators will be able to compare patient data with norms, allowing for more precise diagnostics.
Methods: The study is an age-based cohort study. Participants are children in the age of 6 months to 10 years, without any known hearing or balance problems. The participants are recruited in local nurseries, kinder gardens, and schools. All participants will go through a test protocol consisting of questionnaires, hearing screening and vestibular and postural assessments.
The primary endpoints are age-based norms for v-HIT, c and oVEMP, and posturographic results. The secondary endpoints are number of subjects with successful results of the vestibular test protocol and mean total Dizziness Handicap Inventory for patient caregivers (DHI-PC) score. A number of variables are collected such as demographics, developmental milestones, family history with focus on hearing and balance.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Signe F Bønløkke, PhD student
- Phone Number: +4541405064
- Email: siband@rm.dk
Study Locations
-
-
-
Herning, Denmark, 7400
- Recruiting
- Gødstrup Regional Hospital
-
Contact:
- Signe F Bønløkke, PhD student
- Email: siband@rm.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Children in the age of 6 months -10 years
- Normal hearing
- No history of dizziness or balance problems
- Written informed consent from the parents.
Exclusion Criteria:
- Premature birth
- Existing or previous inner ear disease(s) or previous inner ear surgery
- Cholesteatoma or previous middle ear surgery
- Known or previous vestibular disorder (Vestibular schwannoma, Mb Meniere, vestibular neuritis or other known)
- Delayed gross motor development evaluated through milestones.
- Visual impairment to such a degree that the child is not able to maintain fixation on a dot one meter away.
- Congenital nystagmus
- Compromised eye muscle mobility
- A diagnose of any neurological disease.
- A diagnose of any psychiatric disease.
- VEMP-electrode allergy
- History of symptomatic head or neck trauma
- Prescription of medicine which alters vestibular outputs (for instance sedative antihistamines)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Healthy children without hearing or balance problems
Healthy children in the age of 6 months to 10 years, without any known hearing or balance problems and with normal gross motor development are recruited in local nurseries, kinder gardens, and schools.
|
For v-HIT, the Synapsys v-HIT Ulmer device is used.
Other Names:
For cVEMP, the Eclipse (Interacoustic, Middelfart, Denmark) is used.
To bypass the frequent middle ear problems bone conduction stimuli (B-81, Interacoustic, Middelfart, Denmark) are administrated.
The bone conductor is placed on the mastoid process and two trials at 70 dB nHL are conducted to check waveform reproducibility.
500 Hz short tone bursts (2-2-2 ms) are applied at 5 per second stimulus repetition rate.
Other Names:
For oVEMP, the Eclipse (Interacoustic, Middelfart, Denmark) is used.
To bypass the frequent middle ear problems bone conduction stimuli (B-81, Interacoustic, Middelfart, Denmark) are administrated.
The bone conductor is placed on the mastoid process and two trials at 70 dB nHL are conducted to check waveform reproducibility.
500 Hz short tone bursts (2-2-2 ms) are applied at 5 per second stimulus repetition rate.
Other Names:
To evaluate functional balance of the children and the relative contributions of the vision, proprioception, and vestibular system a CDP from Virtualis (Virtualis, Montpellier, France) is used.
Other Names:
DHI is a caregiver-reported 21-item questionnaire.
It is designed to evaluate the perceived quality of life and handicap resulting from dizziness and unsteadiness for the pediatric population.
For each question there are three possible answers: yes, sometimes or no.
Each answer provides respectively 4, 2 and 0 points.
The total DHI scores range from 0 to 84 with higher score being consistent with more limitation and more severe handicap.
Scores under 16 are characterized as no limitation or handicap.
A score from 16-26 present a mild perceived handicap and mild limitations.
A DHI-score between 26-43 is classified as a moderate problem, and a score above 43 describes a severe perceived handicap and severe limitations.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
video Head Impulse Test (vHIT)
Time Frame: Measured at baseline.
|
Outcome measures: Age-based norms for mean VOR gain
|
Measured at baseline.
|
|
video Head Impulse Test (vHIT)
Time Frame: Measured at baseline.
|
Outcome measures: Age-based norms for VOR gain asymmetry in percent (%).
|
Measured at baseline.
|
|
video Head Impulse Test (vHIT)
Time Frame: Measured at baseline.
|
Outcome measures: Description of saccades (overt and covert saccades)
|
Measured at baseline.
|
|
Cervical Vestibular Evoked Myogenic Potential (cVEMP):
Time Frame: Measured at baseline.
|
Outcome measures: Age-based norms for latency P1 and latency N1 in milliseconds (ms)
|
Measured at baseline.
|
|
Cervical Vestibular Evoked Myogenic Potential (cVEMP):
Time Frame: Measured at baseline.
|
Outcome measures: Age-based norms for rectified interpeak amplitude P1-N1
|
Measured at baseline.
|
|
Cervical Vestibular Evoked Myogenic Potential (cVEMP):
Time Frame: Measured at baseline.
|
Outcome measures: Age-based norms for averaged EMG in µV
|
Measured at baseline.
|
|
Cervical Vestibular Evoked Myogenic Potential (cVEMP):
Time Frame: Measured at baseline.
|
Outcome measures: Age-based norms for left-right asymmetry ratio in percent (%)
|
Measured at baseline.
|
|
Ocular Vestibular Evoked Myogenic Potential (oVEMP):
Time Frame: Measured at baseline.
|
Outcome measures: Age-based norms for latency N1 and latency P1 in milliseconds
|
Measured at baseline.
|
|
Ocular Vestibular Evoked Myogenic Potential (oVEMP):
Time Frame: Measured at baseline.
|
Outcome measures: Age-based norms for interpeak amplitude N1-P1 in µV
|
Measured at baseline.
|
|
Ocular Vestibular Evoked Myogenic Potential (oVEMP):
Time Frame: Measured at baseline.
|
Outcome measures: Age-based norms for left-right asymmetry ratio in percent (%)
|
Measured at baseline.
|
|
Computerized Dynamic Posturography (CDP)
Time Frame: Measured at baseline.
|
Outcome measures: Aged-based norms for Sensory Organization Test (SOT):
|
Measured at baseline.
|
|
Computerized Dynamic Posturography (CDP)
Time Frame: Measured at baseline.
|
Outcome measures: Aged-based norms for motor control test (MCT): • Mean latency of the medium and the big movement respectively in anterior and posterior direction measured in milliseconds. |
Measured at baseline.
|
|
Computerized Dynamic Posturography (CDP)
Time Frame: Measured at baseline.
|
Outcome measures: Aged-based norms for adaptation test (ADT): • Mean sway energy score of toes-up and toes-down respectively. The sway energy score quantifies the force magnitude required to overcome the postural instability. |
Measured at baseline.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dizziness Handicap Inventory for patient caregivers (DHI-PC):
Time Frame: Measured at baseline.
|
Outcome measures: Mean total DHI-PC score.
DHI-PC is a caregiver-reported 21-item questionnaire.
For each question there are three possible answers: yes, sometimes or no.
Each answer provides respectively 4, 2 and 0 points.
The total DHI scores range from 0 to 84 with higher score being consistent with more limitation and more severe handicap.
|
Measured at baseline.
|
|
Success rate of the vestibular test protocol
Time Frame: Measured at baseline
|
Number of subjects with successful results of each of the vestibular assessments.
|
Measured at baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Therese Ovesen, Professor, University Clinic for Balance, Flavour and Sleep, Department of ENT, Gødstrup Hospital, DK
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SFB-2-2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Children, Only
-
Riphah International UniversityCompletedChildren, OnlyPakistan
-
Hospital Authority, Hong KongCompleted
-
Riphah International UniversityRecruiting
-
Semmelweis UniversityRecruitingAnesthesia | Children, OnlyHungary
-
American University of Beirut Medical CenterCompletedAnesthesia | Children, OnlyLebanon
-
University of SaskatchewanCompleted
-
T.C. ORDU ÜNİVERSİTESİUnknownAdolescent | Children, Only
-
St. Justine's HospitalCompletedChildren, Only | Anesthesia; ReactionCanada
-
McMaster UniversityHamilton-Wentworth Catholic District School Board; Start2FinishCompletedPhysical Activity | Children, OnlyCanada
-
Utah State UniversityUtah Agriculture Experiment StationCompletedChildren, Only | Raman SpectroscopyUnited States
Clinical Trials on video Head Impulse Test
-
Tel-Aviv Sourasky Medical CenterUnknownSudden Sensorineural Hearing Loss
-
Meir Medical CenterClalit Health Services, Haifa and West GalileeUnknown
-
Medical Corps, Israel Defense ForceCompleted
-
Jessa HospitalRecruitingHearing Loss, Sensorineural | DFNA9 | Radiology | Bilateral Vestibular DeficiencyBelgium
-
NeurolignMayo Clinic; University of Miami; University of PittsburghActive, not recruitingVestibular Function TestsUnited States
-
University of ZurichCompleted
-
Hospices Civils de LyonCompleted
-
Medical University of South CarolinaCompletedVertigo | Dizziness | Stroke, Acute | Vertigo, Peripheral | Dizziness; SyndromeUnited States
-
University of ZurichCompletedVerticality Perception in Healthy Human Subjects | Individual Contribution of Different Sensory SystemsSwitzerland
-
QHSLab, Inc.ALK-Abelló A/SCompletedHypersensitivity, Immediate | Allergy | Ig-E Mediated FoodUnited States